Sign Up to like & get
recommendations!
2
Published in 2022 at "Annals of Neurology"
DOI: 10.1002/ana.26461
Abstract: Duchenne muscular dystrophy (DMD) exon 45–55 deletion (del45–55) has been postulated as a model that could treat up to 60% of DMD patients, but the associated clinical variability and complications require clarification. We aimed to…
read more here.
Keywords:
dmd exon;
modifying factors;
exon deletion;
phenotypes modifying ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Revista espanola de cardiologia"
DOI: 10.1016/j.rec.2018.03.021
Abstract: I read with great interest the article by Pérez-Sánchez et al., published in Revista Española de Cardiologı́a. The article reports that the phenotypic expression of hypertrophic cardiomyopathy (HCM) is not exclusively due to the necessary…
read more here.
Keywords:
modifying factors;
hypertrophic cardiomyopathy;
phenotypic expression;
disease ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.14695
Abstract: Programmed death ligand‐1 (PD‐L1) expression predicts immunotherapy utility in nononcogenic addictive lung adenocarcinoma (ADC). However, its reproducibility and reliability may be compromised outside clinical trials. This study aimed to evaluate factors associated with PD‐L1 expression…
read more here.
Keywords:
factors expression;
modifying factors;
lung;
expression tumor ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Aging Neuroscience"
DOI: 10.3389/fnagi.2022.968039
Abstract: Statins are a class of widely prescribed drugs used to reduce low-density lipoprotein cholesterol (LDL-C) and important to prevent cardiovascular diseases (CVD). Most statin users are older adults with CVD, who are also at high…
read more here.
Keywords:
factors possible;
cognition modifying;
modifying factors;
underlying mechanisms ... See more keywords